Nuclear targeted x-ray activated photodynamic therapy: a solution to treat pancreatic cancer (Conference Presentation)

Sandhya Clement; Ayad Anwer; Wei Deng; Brian C. Wilson; Christine Allen; Ewa M. Goldys

doi:10.1117/12.2508957

4 March 2019 Nuclear targeted x-ray activated photodynamic therapy: a solution to treat pancreatic cancer (Conference Presentation)

Sandhya Clement, Ayad Anwer, Wei Deng, Brian C. Wilson, Christine Allen, Ewa M. Goldys

Author Affiliations +

Proceedings Volume 10860, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVIII; 1086009 (2019) https://doi.org/10.1117/12.2508957
Event: SPIE BiOS, 2019, San Francisco, California, United States

Abstract

Pancreatic cancer is a highly lethal malignancy and a leading cause of cancer death in the world. Patients are either treated by surgery or by means of radiation therapy or by means of chemotherapy or by combining radiation and chemotherapy together depends upon the status of the pancreatic cancer. All these current treatments have limited efficacy as well as significant toxicity. Photodynamic therapy (PDT) is relatively free from side effects, but it is currently not applicable to pancreatic cancer due to its location in deep tissue. Herein, we developed a PDT system which uses poly (D, L-lactide-co-glycolide) (PLGA) polymeric nanoparticles incorporating a photosensitizer, verteporfin, to generate cytotoxic reactive oxygen species (ROS) by X-ray radiation of 6 MeV. The use of X-ray as the source of energy to trigger verteporfin avoids the limitation of poor penetration depth in conventional PDT. In addition, TAT peptide, a targeting moiety conjugated to the surface of the PLGA nanoconstructs facilitates the targeting of nanoparticles towards the nucleus of the cancer cells. The physiochemical characterisation as well as ROS generation capabilities of the nanoconstructs were studied under 6 MeV X-rays. We believe that the X-ray-induced ROS generation from Verteporfin molecules may be due to Cerenkov radiation (CR) and/or generation of energetic electron by the 6 MeV X-rays which then produce a cascade of ROSs. The cellular experiments carried out in Panc-1 cancer cell line suggest that an improved therapeutic effects can be achieved with the nanoconstructs triggered with X-ray radiation, compared with radiation alone.

Conference Presentation

Citation Download Citation

Sandhya Clement, Ayad Anwer, Wei Deng, Brian C. Wilson, Christine Allen, and Ewa M. Goldys "Nuclear targeted x-ray activated photodynamic therapy: a solution to treat pancreatic cancer (Conference Presentation)", Proc. SPIE 10860, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVIII, 1086009 (4 March 2019); https://doi.org/10.1117/12.2508957

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
PRESENTATION

WATCH
PRESENTATION SAVE TO MY LIBRARY

GET CITATION

KEYWORDS

X-rays

Pancreatic cancer

Photodynamic therapy

Cancer

Nanoparticles

Polymers

Radiotherapy

Show All Keywords

Keywords/Phrases

Search In:

Publication Years